Search research articles
Contact Us
Filters
Showing results (41-50 of 113) with videos related to
Page
of 12
Sort By:
Blood
|
March 25, 2010
Akt isoforms differentially regulate neutrophil functions
Jia Chen, Haiyang Tang, Nissim Hay, et al.
Electrophoresis
|
August 2, 2023
Microfluidic isolation of breast cancer circulating tumor cells from microvolumes of mouse blood
Celine Macaraniag, Jian Zhou, Jing Li, et al.
The Journal of Biological Chemistry
|
May 25, 2010
Akt activation emulates Chk1 inhibition and Bcl2 overexpression and abrogates G2 cell cycle checkpoint by inhibiting BRCA1 foci
Ivana Tonic, Wan-Ni Yu, Youngku Park, et al.
Cancer Research
|
April 22, 2011
Nonredundant functions for Akt isoforms in astrocyte growth and gliomagenesis in an orthotopic transplantation model
Raelene Endersby, Xiaoyan Zhu, Nissim Hay, et al.
The American Journal of Pathology
|
May 14, 2013
Combination of oxidative stress and FOXM1 inhibitors induces apoptosis in cancer cells and inhibits xenograft tumor growth
Marianna Halasi, Bulbul Pandit, Ming Wang, et al.
The Journal of Biological Chemistry
|
December 26, 2001
Increased hexokinase activity, of either ectopic or endogenous origin, protects renal epithelial cells against acute oxidant-induced cell death
Jane M Bryson, Platina E Coy, Kathrin Gottlob, et al.
Journal of the American Chemical Society
|
November 6, 2025
Ketoboronate as a Minimal Covalent-Reversible Tag for Targeted Lysosomal Degradation of Extracellular and Membrane Proteins
Dany Pechalrieu, Veronique Nogueira, Nan Qiu, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
August 21, 2012
The Akt1 isoform is required for optimal IFN-β transcription through direct phosphorylation of β-catenin
Benjamin N Gantner, Huali Jin, Feng Qian, et al.
The Biochemical Journal
|
June 19, 2013
ROS inhibitor N-acetyl-L-cysteine antagonizes the activity of proteasome inhibitors
Marianna Halasi, Ming Wang, Tanmay S Chavan, et al.
Cell Reports
|
July 21, 2015
Systemic Akt1 Deletion after Tumor Onset in p53(-/-) Mice Increases Lifespan and Regresses Thymic Lymphoma Emulating p53 Restoration
Wan-Ni Yu, Veronique Nogueira, Arya Sobhakumari, et al.
Page
of 12
Search research articles
Search
Showing results (41-50 of 113) with videos related to
Sort By:
Page
of 12
Blood
|
March 25, 2010
Akt isoforms differentially regulate neutrophil functions
Jia Chen, Haiyang Tang, Nissim Hay, et al.
Electrophoresis
|
August 2, 2023
Microfluidic isolation of breast cancer circulating tumor cells from microvolumes of mouse blood
Celine Macaraniag, Jian Zhou, Jing Li, et al.
The Journal of Biological Chemistry
|
May 25, 2010
Akt activation emulates Chk1 inhibition and Bcl2 overexpression and abrogates G2 cell cycle checkpoint by inhibiting BRCA1 foci
Ivana Tonic, Wan-Ni Yu, Youngku Park, et al.
Cancer Research
|
April 22, 2011
Nonredundant functions for Akt isoforms in astrocyte growth and gliomagenesis in an orthotopic transplantation model
Raelene Endersby, Xiaoyan Zhu, Nissim Hay, et al.
The American Journal of Pathology
|
May 14, 2013
Combination of oxidative stress and FOXM1 inhibitors induces apoptosis in cancer cells and inhibits xenograft tumor growth
Marianna Halasi, Bulbul Pandit, Ming Wang, et al.
The Journal of Biological Chemistry
|
December 26, 2001
Increased hexokinase activity, of either ectopic or endogenous origin, protects renal epithelial cells against acute oxidant-induced cell death
Jane M Bryson, Platina E Coy, Kathrin Gottlob, et al.
Journal of the American Chemical Society
|
November 6, 2025
Ketoboronate as a Minimal Covalent-Reversible Tag for Targeted Lysosomal Degradation of Extracellular and Membrane Proteins
Dany Pechalrieu, Veronique Nogueira, Nan Qiu, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
August 21, 2012
The Akt1 isoform is required for optimal IFN-β transcription through direct phosphorylation of β-catenin
Benjamin N Gantner, Huali Jin, Feng Qian, et al.
The Biochemical Journal
|
June 19, 2013
ROS inhibitor N-acetyl-L-cysteine antagonizes the activity of proteasome inhibitors
Marianna Halasi, Ming Wang, Tanmay S Chavan, et al.
Cell Reports
|
July 21, 2015
Systemic Akt1 Deletion after Tumor Onset in p53(-/-) Mice Increases Lifespan and Regresses Thymic Lymphoma Emulating p53 Restoration
Wan-Ni Yu, Veronique Nogueira, Arya Sobhakumari, et al.
Page
of 12